Navigation Links
Finland Biotech Delegation Visits Sundia
Date:5/20/2009

SHANGHAI, May 20 /PRNewswire-Asia/ -- A Finland Biotech Delegation visited Sundia MediTech Company, a leading pharmaceutical R&D outsourcing CRO service company in Shanghai, China, in April.

The 9 members of the delegation are from Finnish Funding Agency for Technology and Innovation (Tekes), and three Finnish leading Biotech Companies.

Dr. Xiongwei Shi, Executive Vice President of Sundia MediTech Company, hosted the group and presented to the guests about Sundia's business activities and development strategy. Dr. Pauli Saarenketo, Manager of Tekes, presented Tekes' organization and its functions, especially its Pharmaceutical programs including the Finnish-Chinese Pharmaceutical Collaboration (Research) Program. Delegates from 3 Finnish companies also presented their companies' business as well as CRO needs. Tigermed Consulting Ltd., a strategic alliance partner of Sundia, participated in the meeting.

The Finnish delegates highly praised Sundia's fast growth in recent years, and were very much impressed by Sundia's CRO service capabilities and its state-of-the-art facilities. The hosts and the guests expressed a strong desire for future collaborations.

About Sundia MediTech

Sundia MediTech Company was founded in Shanghai in 2004 by a group of veterans of the US pharmaceutical industry to provide drug discovery and pharmaceutical development CRO services to clients worldwide. Over the past 5 years, Sundia has built a strong reputation as a leading CRO service company in China.

About Tekes Pharma Program

The extensive goal of the Tekes programme Pharma - Building Competitive Edge is to promote the international competitiveness of the Finnish pharmaceutical industry. The programme focuses on the development of operational models and methods to intensify activity and networking within the industry. The creation of new operational models is promoted through networking between pharmaceutical R&D, diagnostics, and clinical research. http://tinyurl.com/qjlnq5

    For more information, please contact:

     Victor Lin
     Sundia MediTech Company
     Tel:   +86-158-0086-7006
     Email: vlin@sundia.com

     Pauli Saarenketo
     Pharma Programme Manager Tekes
     Tel:   +358-10-60-22538
     Email: pauli.saarenketo@tekes.fi

    Sino - Finnish Call for Proposals for Joint R&D Projects
   http://tinyurl.com/fincall

'/>"/>
SOURCE Sundia MediTech Company
Copyright©2009 PR Newswire.
All rights reserved

Related medicine news :

1. Finland Seeks Systemic Changes in Health Care
2. Priligy(TM) (Dapoxetine) Receives First Regulatory Approvals for the Treatment of Premature Ejaculation (PE) in Finland and Sweden
3. Karolinska Development Invests in EvoStem Finland Oy
4. World research leaders gather in Finland to accelerate the development of bioactive paper
5. AMDL, Inc. Enters Into Distribution Agreements With GenWay Biotech, Inc. to Advance Commercialization of the DR-70 (FDP) Cancer Test in the US and Canada
6. BioTech Firm Decodes Current Swine Flu BioMarkers
7. BioTech Medical Well-Positioned to Immediately Respond to Swine Flu Emergency with SDC-Based SpectraSan 24 Disinfectant
8. David Kaye Launches a New Facilities Services Company to Assist the Growing Biotechnology Business in Maryland
9. PRA Hosts Biotech 2009 - Challenges and Opportunities in R&D
10. American Biotech Labs(R) Obtains FDA Approval for New Wound Care Gel Product
11. New Sports Supplement Company to Partner with Indus Biotech
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/26/2017)... BC (PRWEB) , ... July 26, 2017 , ... ... (the “Company” or “Isodiol”) a global cannabis innovator, specializing in the development of ... the period from April 1, 2017 to June 30, 2017. Iso International LLC ...
(Date:7/26/2017)... ... 2017 , ... Wendy M. Musielak, a partner at the Andrew Cores Family Law ... Association’s third Vice President earlier this year. She will serve the membership in this capacity ... President, in accordance with the organization’s by-laws. , Musielak joined the Andrew ...
(Date:7/26/2017)... ... , ... The number of adults 65 years or older is expected to ... control in the population are not well described. In a study published in The ... of the American Academy of Allergy, Asthma & Immunology (AAAAI), researchers identified factors associated ...
(Date:7/25/2017)... PALM SPRINGS, California (PRWEB) , ... July 25, 2017 , ... ... don't involve cranking up the air conditioner — think homemade gourmet ice cream, sparkling ... up inside a gift shop featuring fun mugs, journals, and other must-have knick knacks. ...
(Date:7/25/2017)... ... July 25, 2017 , ... Creative Pharmacist and ... provide the Pharmacist eCare Plan to Computer-Rx pharmacies through the STRAND ... ability to develop the Pharmacist eCare Plan, a shared document detailing a patient’s ...
Breaking Medicine News(10 mins):
(Date:7/12/2017)... 12, 2017  Eli Lilly and Company (NYSE: ... companies to resolve pending patent litigation in the U.S. District ... regarding the Cialis ® (tadalafil) unit dose patent. ... 2020. As part of the agreement, Cialis exclusivity is now ... "The unit dose patent for Cialis is valid ...
(Date:7/11/2017)... LINCOLNSHIRE, Ill. , July 11, 2017 /PRNewswire/ ... hematology and urinalysis diagnostic testing equipment as well ... latest innovation: a way to make quality assurance ... control processes. "Sysmex is well known for the ... SM Quality Monitor elevates quality assurance processes ...
(Date:7/10/2017)... 2017 The Institute for In Vitro Sciences ... recipient of a VITROCELL® inhalation exposure system thanks to ... The device, which is designed to replace animals in ... cells to airborne test materials in an environment that ... system for testing combustible tobacco products, as well as ...
Breaking Medicine Technology: